Genotype Gly/Gly of the Arg16Gly polymorphism of the β 2-adrenergic receptor is associated with elevated fasting serum insulin concentrations, but not with acute insulin response to glucose, in type 2 diabetic patients

Diabetes Research and Clinical Practice

Volumn 63, Issue 1, 2004, Pages 11-18

  Ikarashi, Tomoo ^a   Hanyu, Osamu ^a   Maruyama, Seitaro ^a   Souda, Satoshi ^a   Kobayashi, Chiaki ^a   Abe, Eri ^a   Ukisu, Jyunko ^a   Naganuma, Keiko ^a   Suzuki, Akiko ^a   Toya, Maki ^a   Kaneko, Susumu ^a   Suzuki, Katsunori ^a   Nakagawa, Osamu ^a   Aizawa, Yoshifusa ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

Author keywords

Genetic polymorphism; Insulin secretion; Type 2 diabetes mellitus; 2 Adrenergic receptor

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; C REACTIVE PROTEIN; CATECHOLAMINE; FATTY ACID; GLUCOSE; HEMOGLOBIN A1C; HUMAN INSULIN; URIC ACID DERIVATIVE;

ALLELE; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENOTYPE; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; LIPID BLOOD LEVEL; LIPOLYSIS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STATISTICAL SIGNIFICANCE;

EID: 0345730916     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2003.08.010     Document Type: Article

References (35)

1. L.J. Raffel, M.T. Scheuner, J.I. Rotter, Genetics of diabetes, in: D. Porte, R.S. Sherwin (Eds.), Ellenberg & Rifkin's Diabetes Mellitus: Theory and Practice, fifth ed., Appleton & Lange, Stamford, 1997, pp. 401-454.
2. Groop L.C., Tuomi T. Non-insulin-dependent diabetes mellitus - a collision between thrifty genes and an affluent society. Ann. Med. 29:1997;37-53.
3. Alberti K.G.M.M., Zimmet P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 15:1998;539-553.
4. K.D. Silver, A.R. Shuldiner, Candidate genes for type 2 diabetes mellitus, in: D. LeRoith, S.I. Taylor, J.M. Olefsky (Eds.), Diabetes Mellitus: A Fundamental and Clinical Text, second ed., Lippincott Williams & Wilkins, Philadelphia, 2000, pp. 705-719.
5. 3-adrenergic receptor. J. Clin. Endocrinol. Metab. 85:2000;4019-4022.
6. 3-adrenoceptor in man. J. Clin. Invest. 95:1995;2239-2245.
7. 3-adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue. Br. J. Pharmacol. 117:1996;907-913.
8. S. Guimarães, D. Moura, Vascular adrenoceptors: an update, Pharmacol. Rev. 53 (2001) 319-356 (erratum in Pharmacol. Rev. 53 (2001) 451).
9. Lacey R.J., Cable H.C., James RF R.F.et al. Concentration-dependent effects of adrenaline on the profile of insulin secretion from isolated human islets of Langerhans. J. Endocrinol. 138:1993;555-563.
10. 2-adrenoceptor function. J. Clin. Invest. 100:1997;3005-3013.
11. Welch S., Gebhart S.S., Bergman R.N., Phillips L.S. Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects. J. Clin. Endocrinol. Metab. 71:1990;1508-1518.
12. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28:1985;412-419.
13. Best J.D., Kahn S.E., Ader M., Watanabe R.M., Ni T.C., Bergman R.N. Role of glucose effectiveness in the determination of glucose tolerance. Diabetes Care. 19:1996;1018-1030.
14. Bergman R.N., Ider Y.Z., Bowden C.R., Cobelli C. Quantitative estimation of insulin sensitivity. Am J. Physiol. 236:1979;E667-E677.
15. Pacini G., Bergmann R.N. MINMOD - a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput. Methods Programs Biomed. 23:1986;113-122.
16. Guidelines Subcommittee of the Japanese Society of Hypertension (Ed.), Guidelines for the Management of Hypertension (JSH 2000), Japanese Society of Hypertension, Tokyo, 2000 (in Japanese).
17. M.D. Davis, F.L. Myers, G.H. Bresnick, Natural evolution, in: F.A. L'Esperance Jr. (Ed.), Current Diagnosis and Management of Chorioretinal Disease, Mosby, St. Louis, 1977, pp. 179-184.
18. American Diabetes Association, Diabetic nephropathy, Diabetes Care 22 (1999) S66-S69.
19. Insel P.A. Adrenergic receptors - evolving concepts and clinical implications. N. Engl. J. Med. 334:1996;580-585.
20. Johnson M. The β-adrenoceptor. Am. J. Respir. Crit. Care Med. 158:1998;S146-S153.
21. 2-adrenoceptor. Hypertension. 30:1997;773-776.
22. 2-Adrenergic receptor variants affect resting blood pressure and agonist-induced vasodilation in young adult Caucasians. Hypertension. 33:1999;1425-1430.
23. O'Byrne S., Caulfield M. Genetics of hypertension: therapeutic implications. Drugs. 56:1998;203-214.
24. 2- adrenergic receptor function. J. Allergy Clin. Immunol. 104:1999;S42-S46.
25. 2-adrenergic receptor impart distinct agonist-promoted regulatory properties, Biochemistry 33 (1994) 9414-9419 (erratum in Biochemistry 33 (1994) 14368).
26. 2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells. Am. J. Respir. Cell Mol. Biol. 13:1995;25-33.
27. 2-Adrenergic receptor gene variations, blood pressure, and heart size in normal twins. Hypertension. 35:2000;555-560.
28. 2-Adrenergic receptor gene variation and hypertension in subjects with type 2 diabetes. Hypertension. 37:2001;1303-1308.
29. 2-Adrenoceptor genetic variation is associated with genetic predisposition to essential hypertension: the Bergen Blood Pressure Study. Kidney Int. 53:1998;1455-1460.
30. Låfontan M., Berlan M. Fat cell adrenergic receptors and the control of white and brown fat cell function. J. Lipid Res. 34:1993;1057-1091.
31. Arner P. Differences in lipolysis between human subcutaneous and omental adipose tissues. Ann. Med. 27:1995;435-438.
32. 2-Adrenoceptor gene polymorphism and obesity. Lancet. 353:1999;1976.
33. Boden G., Chen X., Rosner J., Barton M. Effects of a 48-h fat infusion on insulin secretion and glucose utilization. Diabetes. 44:1995;1239-1242.
34. G. Boden, Role of fatty acids in the pathogenesis of insulin resistance and NIDDM, Diabetes 46 (1997) 3-10 (erratum in Diabetes 46 (1997) 536).
35. Bollheimer L.C., Skelly R.H., Chester M.W., McGarry J.D., Rhodes C.J. Chronic exposure to free fatty acid reduces pancreatic β cell insulin content by increasing basal insulin secretion that is not compensated for by a corresponding increase in proinsulin biosynthesis translation. J. Clin. Invest. 101:1998;1094-1101.